GMP IWR-1-endo Ancillary Material

GMP IWR-1-endo Ancillary Material
Product Description

This product has been manufactured and tested in accordance with GMP principles set forth by the ICH and FDA and meets the expectations for commercial cell, gene, and tissue-engineered products in accordance with USP <1043> “Ancillary Materials for Cell, Gene, and Tissue-engineered Products”.

WARNING This product is not for human or veterinary use.

Cayman Chemical Company

  • Country/Region:
    United States
  • Founded:
    1980
  • On CPHI since:
    2021
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
Generic APIs producer
Specifications
  • CAS Registry Number
    1127442-82-3
  • Details
    IWR-1-endo is an inhibitor of the Wnt signaling pathway that acts via inhibition of tankyrases and stabilization of axin. It has been used to maintain proliferation of hematopoietic stem cells, promote pluripotency of human embryonic stem cells, and induce differentiation of progenitor cells. GMP IWR-1-endo Ancillary Material is intended for use in cell, gene, and tissue engineering applications.
  • Selling Points
    Experienced Technicians; Price; Product Performance; Reputation
  • Model
    44886
  • Supplied from
    United States
  • Measured In
    milligram

Cayman Chemical Company

  • Country/Region:
    United States
  • Founded:
    1980
  • On CPHI since:
    2021
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
Generic APIs producer

More Products from Cayman Chemical Company (20)

  • GMP (±)-Cloprostenol sodium salt

    Product GMP (±)-Cloprostenol sodium salt

    (±)-Cloprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material, which conforms to the USP and BVP Monographs, is available. The DMF is on file with the US FDA, Canada, Russia, in almost all EU member states, and in many other countries.
  • GMP (−)-(R)-Methamphetamine (hydrochloride)

    Product GMP (−)-(R)-Methamphetamine (hydrochloride)

    (-)-(R)-Methamphetamine (hydrochloride) is manufactured at Cayman Chemical in Ann Arbor, MI. GMP material appropriate for clinical trials is available.
  • GMP 3,4-MDMA

    Product GMP 3,4-MDMA

    3,4-MDMA is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is under development.
  • GMP Bimatoprost

    Product GMP Bimatoprost

    Bimatoprost is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Bimatoprost is on file with the US FDA, Canada, and India.
  • GMP DMT Hemifumarate

    Product GMP DMT Hemifumarate

    DMT Hemifumarate is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is available.
  • GMP Epoprostenol sodium salt

    Product GMP Epoprostenol sodium salt

    Epoprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF is on file with the US FDA, Canada, Japan, Australia, and many EU member states.
  • GMP Latanoprost

    Product GMP Latanoprost

    Latanoprost is manufactured at Cayman Chemical in Ann Arbor, MI and at Cayman Pharma, our Czech subsidiary. GMP material from both Cayman Chemical and Cayman Pharma, which conforms to the USP, EP, and IP Monographs, is available. Each site maintains a unique DMF; they have been filed with the US FDA, Canad...
  • GMP Latanoprostene Bunod

    Product GMP Latanoprostene Bunod

    Latanoprostene Bunod is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Latanoprostene Bunod is available for customer review upon request.
  • GMP Psilocin

    Product GMP Psilocin

    Psilocin is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is available.
  • GMP Psilocybin

    Product GMP Psilocybin

    Psilocybin is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is available.
  • GMP SM-102

    Product GMP SM-102

    M-102 is manufactured as an excipient suitable for use in LNP preparation and small molecule encapsulation at Cayman Chemical in Ann Arbor, MI. GMP material appropriate for clinical trials is available. (NOTE: This product is subject to licensing for use in commercial applications.)
  • GMP Tafluprost

    Product GMP Tafluprost

    Tafluprost is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Tafluprost is available for customer review upon request. The DMF has been filed with the US FDA and in Russia.